Equity
€110,253 from €1.1m in 2015
Equity fell by 90% in 10 years.
DName-iT
Lifetime
11 annual accounts with figures on one time axispeak €50,066 (2020)
-€71,430▼ €33,104
lowest -€435,040 (2016)
-€74,453▼ €33,228
peak €1.1m (2015)
€110,253▼ 40.3%
€402,201▲ 25.7%
peak 1 FTE (2015)
-not published
Board21 names since 2014all names
1 director
Documentsfilings and deeds
25-08-202625 days late
2025abbreviated format
Gross margin from -€38,327 to -€71,430Loss of €74,453Equity from €184,706 to €110,253Debts from €319,875 to €402,201Cash from €1,572 to €11,233
Key points
from the 2025 annual accountsLosses
-€241,010 in five years
Every financial year from 2021 to 2025 closed with a loss. 2025 was the heaviest.
Debts
€402,201 78% of the balance sheet
After one year 2%Within one year 98%
Of this, €396,160 falls due within a year.
At the same address
23 companies
Board
1 joined · 1 left
Board changed. Latest change 01-01-2026 · 1 in office.
Position in the sector
-€74,453
Lower net result than 95% of companies in human health. Sector median €125,403 · 2,767 companies.
2025 accounts filed 25 days after the deadlineTurnover not published (abbreviated format)
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 182 companies had the same profile as DName-iT has now. Each dot is one company, two years later.
91.2%
were still trading
2.7%
stopped another way
5.5%
went bankrupt
Another 0.5% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 182 companies, not a prediction for DName-iT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
1 director appointed, 1 resignation
Resignation: · Permanent representatives: and · Appointment: · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0506754823
1 director appointed, 2 resignations
Resignations: (class B director) and (independent director) · Appointment: (sole director) · Permanent representative: · General meeting of 22-12-2020 · Gazette deed
3 directors appointed, 3 resignations
Resignations: , and · Appointments: , and · Permanent representatives: and · General meeting of 16-04-2019 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DName-iT Leuven | €0.5m | -€71,430 | 21.5% | - |
| ABBIO Watermael-Boitsfort | €0.4m | -€97,079 | -22.6% | - |
| AMAKEM Hasselt | €0.4m | -€8,122 | 100.0% | - |
| CRYOSTORAGE Ghent | €0.4m | -€453 | -30.2% | - |
| DANOS LABORATORY Ixelles | €0.3m | -€27,299 | 38.0% | - |
| Expert Service & Advice in Healthcare Hoeilaart | €1.1m | -€857 | 98.2% | - |
| FHP Bornem | €0.8m | -€91,475 | 99.4% | - |
These companies have the same main activity as DName-iT: medical imaging and medical laboratories (NACE 86910). They are comparable in size and age: total assets between €298,000 and €1.1m, founded between 2008 and 2021.
Official details
Source: KBO- Status
- Active since 11-12-2014Normal situation
- Registered office
- 24 active companies are registered at this address1 started in the 12 months before. Source: KBO register, as of 14 November 2026.
- Activity
- Medical imaging and medical laboratoriesNACE 86910and 1 other
- Establishment unit
- 2.239.018.1383001 Leuven, since 11-12-2014
- Financial year end
- 31 December
- Peppol
- Reachable since 02-07-2025
Insights on DName-iT
DName-iT files the abbreviated format. That format states no turnover. The gross margin rose from -€215,882 in 2015 to -€71,430 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DName-iT
- What is the company number of DName-iT?
- The company number of DName-iT is 0506.754.823. The VAT number is the same number with BE in front: BE 0506.754.823.
- Where is DName-iT based?
- The registered office is at Gaston Geenslaan 1, 3001 Leuven.Company details
- What does DName-iT do?
- According to the KBO register, the main activity is medical imaging and medical laboratories (NACE 86910).
- What is the legal form of DName-iT?
- DName-iT is a public limited company (NV).
- When was DName-iT founded?
- DName-iT was founded on 11-12-2014.
- Is DName-iT still active?
- Yes, DName-iT is an active enterprise in the KBO register.
- What is the turnover of DName-iT?
- The annual accounts for financial year 2025 state no turnover. The abbreviated format does not require it.Financials
- Is DName-iT profitable?
- In financial year 2025, DName-iT made a loss of €74,453.
- Where can I find the annual accounts of DName-iT?
- DName-iT filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DName-iT due?
- DName-iT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.